EMP

EMP is the successful collaboration outcome of PharmaMatch and Pharma-Data, with its main office located in Amstelveen, Netherlands. The company's R&D center in Athens, Greece, specializes in product development for pharmaceutical formulations and is GMP-certified. Since commencing operations in 2007, EMP has become an expert in the international pharmaceuticals market, successfully developing an oral solution of levothyroxine. EMP’s levothyroxine oral solution has received patent protection in the EU and the US and was used by British Pharmacopoeia as a reference product for establishing the relevant official monograph.